dihexa fda approval to Review Peptides Backed by RFK Jr for Compounding Pharmacies π Full story & link in the comments HHS Secretary Kennedy announced that
HHS Secretary Kennedy announced that the FDA is pulling 12 peptides off the Category 2 do not compound list and sending them for scientific review in July. THANK YOU @robertfkennedyjr The 12 Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted Undercutting HHS Secretary Robert F. Kennedy Jr.'s recent push to expand access to peptides, FDA career scientists determined there isn't adequate evidence to support any of the ones under consideration for production Dihexa Peptide: Complete Guide to Synaptogenesis (2026) EllieMD Dihexa DIHEXA Beverly Hills Rejuvenation Center
Pay in 4 interest-free payments of $6.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 4 - Aug 9


